Viridian Therapeutics, Inc./DE Lessee, Operating Lease, Discount Rate
Viridian Therapeutics, Inc./DE (VRDN) had Lessee, Operating Lease, Discount Rate of 6.00% as of 2021-03-31, per its 10-Q filed 2024-08-08.
Discontinued › Notes › Leases
us-gaap:LesseeOperatingLeaseDiscountRate · last filed 2024-08-08
- 2021-03-31: Lessee, Operating Lease, Discount Rate 6.00%.
- 2020-10-31: Lessee, Operating Lease, Discount Rate 6.00%.
- 2020-03-31: Lessee, Operating Lease, Discount Rate 6.00%.
- 2020-01-01: Lessee, Operating Lease, Discount Rate 6.00%.
| Period end | Lessee, Operating Lease, Discount Rate |
|---|---|
| 2021-03-31 | 6.00% 10-Q · filed 2024-08-08 |
| 2020-10-31 | 6.00% 10-Q · filed 2024-08-08 |
| 2020-03-31 | 6.00% 10-Q · filed 2020-05-08 |
| 2020-01-01 | 6.00% 10-K · filed 2022-03-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| Zai Lab Ltd (ZLAB) | $2.241B | -113.34 | |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| Aurinia Pharmaceuticals Inc. (AUPH) | $2.207B | 7.18 | |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Prestige Consumer Healthcare Inc. (PBH) | United States | $2.163B | 13.03 |